1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow Neurological Complication: new trials by email Literature Review of Neurological Complication trials Research Report on Neurological Complication
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Efficacy, and Dosing of VIX001 in Patients With Neurological Symptoms of Post Acute COVID-19 Syndrome (PACS). VIX001 - Post-Acute COVID-19 Syndrome, Cognitive Impairment | Phase 1 | Unknown | Neobiosis, LLC | 9 | 2023-10-01 | 2023-07-17 |
COVID-19 (1) · Cognitive Dysfunction (1) · Neurologic Manifestations (1) · Post-Acute COVID-19 Syndrome (1)
Chronic Disease (1) · Cognition Disorders (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Disease Attributes (1) · Infections (1) · Lung Diseases (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Nidovirales Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pneumonia (1) · Pneumonia, Viral (1)
Neobiosis, LLC (1)